Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

somatostatin receptor imaging

  • You have access
    64Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Prospective, Head-to-Head Comparison of Imaging at 1 Hour and 3 Hours After Injection
    Mathias Loft, Esben A. Carlsen, Camilla B. Johnbeck, Helle H. Johannesen, Tina Binderup, Andreas Pfeifer, Jann Mortensen, Peter Oturai, Annika Loft, Anne K. Berthelsen, Seppo W. Langer, Ulrich Knigge and Andreas Kjaer
    Journal of Nuclear Medicine January 1, 2021, 62 (1) 73-80; DOI: https://doi.org/10.2967/jnumed.120.244509
  • You have access
    A Prospective Observational Study to Evaluate the Effects of Long-Acting Somatostatin Analogs on 68Ga-DOTATATE Uptake in Patients with Neuroendocrine Tumors
    Anni Gålne, Helen Almquist, Martin Almquist, Cecilia Hindorf, Tomas Ohlsson, Erik Nordenström, Anna Sundlöv and Elin Trägårdh
    Journal of Nuclear Medicine December 1, 2019, 60 (12) 1717-1723; DOI: https://doi.org/10.2967/jnumed.119.226332
  • You have access
    Evaluating the Role of Theranostics in Grade 3 Neuroendocrine Neoplasms
    Najeff Waseem, Carina Mari Aparici and Pamela L. Kunz
    Journal of Nuclear Medicine July 1, 2019, 60 (7) 882-891; DOI: https://doi.org/10.2967/jnumed.118.217851
  • You have access
    Long-Acting Somatostatin Analog Therapy Differentially Alters 68Ga-DOTATATE Uptake in Normal Tissues Compared with Primary Tumors and Metastatic Lesions
    Narjess Ayati, Sze Ting Lee, Rasoul Zakavi, Kunthi Pathmaraj, Louai Al-Qatawna, Aurora Poon and Andrew M. Scott
    Journal of Nuclear Medicine February 1, 2018, 59 (2) 223-227; DOI: https://doi.org/10.2967/jnumed.117.192203
  • You have access
    Head-to-Head Comparison of 64Cu-DOTATATE and 68Ga-DOTATOC PET/CT: A Prospective Study of 59 Patients with Neuroendocrine Tumors
    Camilla B. Johnbeck, Ulrich Knigge, Annika Loft, Anne K. Berthelsen, Jann Mortensen, Peter Oturai, Seppo W. Langer, Dennis R. Elema and Andreas Kjaer
    Journal of Nuclear Medicine March 1, 2017, 58 (3) 451-457; DOI: https://doi.org/10.2967/jnumed.116.180430
  • You have access
    The Impact of 68Ga-DOTATATE PET/CT Imaging on Management of Patients with Neuroendocrine Tumors: Experience from a National Referral Center in the United Kingdom
    Evangelia Skoura, Sofia Michopoulou, Mullan Mohmaduvesh, Emmanouil Panagiotidis, Mohammed Al Harbi, Christos Toumpanakis, Omar Almukhailed, Irfan Kayani, Rizwan Syed, Shaunak Navalkissoor, Peter J. Ell, Martyn E. Caplin and Jamshed Bomanji
    Journal of Nuclear Medicine January 1, 2016, 57 (1) 34-40; DOI: https://doi.org/10.2967/jnumed.115.166017
  • You have access
    In Vivo Evaluation of 18F-SiFAlin–Modified TATE: A Potential Challenge for 68Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET
    Sabrina Niedermoser, Joshua Chin, Carmen Wängler, Alexey Kostikov, Vadim Bernard-Gauthier, Nils Vogler, Jean-Paul Soucy, Alexander J. McEwan, Ralf Schirrmacher and Björn Wängler
    Journal of Nuclear Medicine July 1, 2015, 56 (7) 1100-1105; DOI: https://doi.org/10.2967/jnumed.114.149583
  • You have access
    64Cu-DOTATATE PET for Neuroendocrine Tumors: A Prospective Head-to-Head Comparison with 111In-DTPA-Octreotide in 112 Patients
    Andreas Pfeifer, Ulrich Knigge, Tina Binderup, Jann Mortensen, Peter Oturai, Annika Loft, Anne Kiil Berthelsen, Seppo W. Langer, Palle Rasmussen, Dennis Elema, Eric von Benzon, Liselotte Højgaard and Andreas Kjaer
    Journal of Nuclear Medicine June 1, 2015, 56 (6) 847-854; DOI: https://doi.org/10.2967/jnumed.115.156539
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire